Migraine Pack
NDC Package 69176-150-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Migraine Pack is sumatriptan tablets are indicated for the acute treatment of migraine attacks with or without aura in adults.Sumatriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Marketed by Tmig Inc, this product is identified by NDC 69176-150 and is authorized under FDA application ANDA078327.

Identification & Billing

NDC Package Code
69176-150-01
Package Description
1 KIT in 1 PACKAGE * 9 BLISTER PACK in 1 CARTON (65862-147-36) / 9 TABLET in 1 BLISTER PACK * 50 mL in 1 BOTTLE, PUMP (63936-870-01)
Product Code
69176-150
11-Digit Billing Format
69176015001
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Migraine Pack
Dosage Form
-
Usage Information
Sumatriptan tablets are indicated for the acute treatment of migraine attacks with or without aura in adults.Sumatriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Safety and effectiveness of sumatriptan tablets have not been established for cluster headache, which is present in an older, predominantly male population.

Regulatory & Marketing

Labeler Name
Tmig Inc
FDA Application #
ANDA078327
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-13-2017
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69176-150-01 identifies a specific commercial package of 1 kit in 1 package * 9 blister pack in 1 carton (65862-147-36) / 9 tablet in 1 blister pack * 50 ml in 1 bottle, pump (63936-870-01) of Migraine Pack, labeled by Tmig Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tmig Inc on January 13, 2017. The current certification is valid through December 31, 2020.

How is this Tmig Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69176015001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69176-150-01
11-Digit CMS (5-4-2)
69176-0150-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.